Diabetes In Adolescence

3

Review clinical trials related to Diabetes In Adolescence. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

MiniMed Fit Payload Wear Pediatric Study

The purpose of this study is to assess MiniMed Fit Payload adhesive components in different wear locations over a 7-day period to support development of the future commercialized patch pump in participants 7-17 years of age.

Participants needed: 100
Trial details
Age: 7-17Biological sex: AllType: ObservationalSponsor: Medtronic MiniMed, Inc.Updated: Jun 30, 2026
Eligibility criteria

Participants with insulin-requiring diabetes [+2]

Participants who report known skin sensitivity or allergy to polycarbonate or pr... [+2]

Status: Recruiting

Pilot-Testing Strategies to Improve Outcomes for Youth With Type 2 Diabetes by Addressing Health-Related Social Needs

The goal of this clinical trial is to pilot test different strategies to address health related social needs (HRSN) experienced by adolescent and young adult patients with type 2 diabetes and their families. The main questions it aims to answer are: * How feasible are the strategies? * How acceptable are the strategies? * How reliably and consistently can the strategies be implemented? Participants will: Attend regularly scheduled diabetes clinic visits. Complete surveys and interviews. Be connected to community resources and organizations to help address HRSN.

Participants needed: 104
Trial details
Age: 13+Biological sex: AllType: InterventionalSponsor: University of PittsburghUpdated: Apr 27, 2026Locations: 1
Eligibility criteria

Age 13 to 22 years old [+6]

Inability to complete study questionnaires in English

Status: Recruiting

Brain Health in Youth With Normal Weight, Overweight and Obesity at Risk for Type 2 Diabetes (T2D)

Investigators propose to study youth across the spectrum of body mass index (BMI) and dysglycemia. This approach will allow investigators to disentangle the relationship of key features of type 2 diabetes (T2D) risk (e.g. obesity) with intermediary physiologic changes (e.g. insulin resistance, inflammation, β-cell dysfunction and dysglycemia) that pose a risk for the brain. Investigators will determine which of these factors are most associated with differences in brain structure and function among groups, over time, and how these effects differ from normal neurodevelopment.

Participants needed: 117
Trial details
Age: 12-17Biological sex: AllType: ObservationalSponsor: Washington University School of MedicineUpdated: Dec 18, 2025Locations: 2
Eligibility criteria

12-17 yrs. old at visit 1, 12-19 yrs. old at visit 2, Tanner II or above (determ...

Syndromic obesity, history of bariatric surgery, insulin treatment (metformin al...